Strong Q4 Revenue Growth
Q4 revenue of $152.7M, up 32.6% FX-neutral year-over-year; FX provided a ~270 basis point reported tailwind. Organic FX-neutral growth excluding Sertifi was 20%.
Transaction Volume and Revenue Momentum
Transaction revenue increased 33% year-over-year driven by a 42% increase in transaction payment volume.
Platform Revenue Acceleration
Platform & Other revenues grew 50% year-over-year, with platform-related volumes up 11%, helped by Sertifi and healthcare patient affordability momentum.
Gross Profit and Margin Expansion
Adjusted gross profit was $93.7M, up nearly 24% year-over-year, with adjusted gross margin at 61.3% despite mix and FX settlement dynamics.
Profitability and Cash Generation
Adjusted EBITDA margin expanded to 16.6% in Q4 (up ~190 bps YoY) and full-year GAAP net income was $13.5M. Free cash flow grew from $5M in 2021 to $62M in 2025.
Client Wins and Low Churn
Signed ~750 net new clients in 2025; revenue churn in education and travel remained below 1%. Over 90% of education revenue and 70%+ of travel revenue came from enterprise clients (> $100k LTM).
Sales & Pipeline Momentum
Signed ARR grew over 35% YoY; pipeline creation entering 2026 increased ~35% YoY. SFS (Student Financial Software) ARR from signed deals grew more than threefold year-over-year.
Balance Sheet Strength and Buybacks
Net cash position was $200M. $118M of share repurchases deployed under the program with ~$180M remaining authorized; diluted shares declined year-over-year (negative net dilution for 2025).
2026–2027 Profitability Outlook
2026 guidance: FX-neutral revenue growth 15%–21%; adjusted EBITDA margin expansion of ~150–350 bps to reach ~22.5% at midpoint. Targeting 24%–25% adjusted EBITDA margin for 2027.
Capital Efficiency Targets
Expected 2026 free cash flow conversion of 70%–75%; GAAP net income expected to grow ~3–4x vs 2025. Target net dilution ~3% and stock-based compensation targeted ~10% of revenue in 2026.